leadf
logo-loader
viewBB Healthcare Trust PLC
(
LSE:BBH
)

BB Healthcare Trust outperforms the Healthcare sector

"We are very much investing on a 'post-pandemic' basis and are pleased that we have felt confident to return to having a broad-based portfolio compared to the summer of 2020"

BB Healthcare Trust PLC -

BB Healthcare Trust PLC (LON:BBH) saw its net asset value per share rise 9.75p to 182.26p in the six months to the end of May.

The net asset value (NAV) figure includes dividends paid out during the period. The NAV total return in the period was +7.1%, compared to +13.3% in the corresponding period 12 months earlier. Over the same time frame, the trust’s benchmark index, the MSCI World Healthcare Index, achieved a total return of +3.9%.

During the first half of the trust’s fiscal year, exposure to Healthcare Information Technology (IT) and Healthcare Technology sectors was scaled back, largely on valuation grounds, although the market’s rotation into valuation stocks has enabled the trust to more or less build back its exposure to these two sectors.

The commitment to the Diagnostics sector was reduced as prices got toppy but the investment manager has begun to rebuild exposure to this sector. The Dental sector is regarded as too expensive but the Services and Tools sectors continue to be attractive owing to highly visible and predictable growth.

An interim dividend of 3.015p has been declared, being exactly half of the full-year target dividend of 6.03p; as usual, a scrip dividend alternative will be available to shareholders.

In his commentary on the FTSE 250 group’s half-year results, chair Randeep Grewal noted the company's shares continued to trade at a modest premium of 1.2% to NAV, on average, over the period in review, albeit with a slightly more elevated level of volatility in the premium.

The investment manager said markets at present are not obviously cheap when thinking about the price of growth compared to historical norms and there are some lingering political headwinds, such as pressure on the US government to reform a healthcare system that is among the most expensive in the Western world.

As for the pandemic, the investment manager’s expectations are for normalisation in procedure volumes toward the end of the year” and this seems to be well priced, in terms of both valuations and consensus expectations”.

Use of the currently available surgical capacity should continue to improve but the investment manager thinks it is unrealistic to expect system-wide capacity will return to normal levels until the “pandemic is firmly in the rear-view mirror”.

“We would broadly agree with the notion that the second half [H2] of the year could prove more tricky for equity investors than H1 2021 has been. Within this though, healthcare feels well placed to us. The restrictions impacting us all are slowly abating and the innate demand for healthcare services is undiminished. As such, we can be very confident in the broader positive fundamental outlook for healthcare during H2 2021 and beyond and as such, we do not expect healthcare to underperform the wider market in the manner that it did during the first half of the year,” the company said.

Shares in BB Healthcare Trust were unchanged in early deals.

Quick facts: BB Healthcare Trust PLC

Follow
LSE:BBH

Price: 193.6 GBX

Market Cap: £1.07 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

BB Healthcare Trust: The impact of US President Joe Biden's administration...

BB Healthcare Trust's (LON:BBH) Brett Darke joins Proactive London's Katie Pilbeam to discuss the impact of US President Joe Biden's administration on the healthcare sector so far.  More than six months in, Darke explains how his expectations of a Biden reign compare to the reality of what...

on 26/7/21

3 min read